Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Dichloroacetate and cancer: New home for an orphan drug?
Shyam Kankotia, Peter W. Stacpoole
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2014) Vol. 1846, Iss. 2, pp. 617-629
Closed Access | Times Cited: 202

Showing 26-50 of 202 citing articles:

mTOR-mediated cancer drug resistance suppresses autophagy and generates a druggable metabolic vulnerability
Niklas Gremke, Pierfrancesco Polo, Aaron Dort, et al.
Nature Communications (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 121
Therapeutic applications of dichloroacetate and the role of glutathione transferase zeta-1
Margaret O. James, Stephan C. Jahn, Guo Zhong, et al.
Pharmacology & Therapeutics (2016) Vol. 170, pp. 166-180
Open Access | Times Cited: 119
Competitive glucose metabolism as a target to boost bladder cancer immunotherapy
Julieta Afonso, Lúcio Lara Santos, Adhemar Longatto‐Filho, et al.
Nature Reviews Urology (2020) Vol. 17, Iss. 2, pp. 77-106
Closed Access | Times Cited: 113
In vitro and in vivo anticancer activity of tridentate thiosemicarbazone copper complexes: Unravelling an unexplored pharmacological target
Mauro Carcelli, Matteo Tegoni, Jennifer Bartoli, et al.
European Journal of Medicinal Chemistry (2020) Vol. 194, pp. 112266-112266
Closed Access | Times Cited: 112
SLC transporters as a novel class of tumour suppressors: identity, function and molecular mechanisms
Yangzom D. Bhutia, Ellappan Babu, Sabarish Ramachandran, et al.
Biochemical Journal (2016) Vol. 473, Iss. 9, pp. 1113-1124
Open Access | Times Cited: 101
Investigation of inhibitory potential of quercetin to the pyruvate dehydrogenase kinase 3: Towards implications in anticancer therapy
Rashmi Dahiya, Taj Mohammad, Sonam Roy, et al.
International Journal of Biological Macromolecules (2019) Vol. 136, pp. 1076-1085
Closed Access | Times Cited: 97
Dichloroacetate restores colorectal cancer chemosensitivity through the p53/miR-149-3p/PDK2-mediated glucose metabolic pathway
Yu Liang, Lidan Hou, Linjing Li, et al.
Oncogene (2019) Vol. 39, Iss. 2, pp. 469-485
Open Access | Times Cited: 92
De novo phosphatidylcholine synthesis is required for autophagosome membrane formation and maintenance during autophagy
Gabriela Andrejeva, Sharon Gowan, Gigin Lin, et al.
Autophagy (2019) Vol. 16, Iss. 6, pp. 1044-1060
Open Access | Times Cited: 85
Metal- and metalloid-based compounds to target and reverse cancer multidrug resistance
Andreia Valente, Ana Podolski-Renić, Isabella Poetsch, et al.
Drug Resistance Updates (2021) Vol. 58, pp. 100778-100778
Open Access | Times Cited: 76
Redox Homeostasis and Metabolism in Cancer: A Complex Mechanism and Potential Targeted Therapeutics
Alia Ghoneum, Ammar Yasser Abdulfattah, Bailey Warren, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 9, pp. 3100-3100
Open Access | Times Cited: 73
Regulating mitochondrial metabolism by targeting pyruvate dehydrogenase with dichloroacetate, a metabolic messenger
Nick Schoenmann, Nicholas Tannenbaum, Ryan Hodgeman, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2023) Vol. 1869, Iss. 7, pp. 166769-166769
Open Access | Times Cited: 29
Restoration of mitochondria function as a target for cancer therapy
Tariq A. Bhat, Sandeep Kumar, Ajay Kumar Chaudhary, et al.
Drug Discovery Today (2015) Vol. 20, Iss. 5, pp. 635-643
Open Access | Times Cited: 85
Selective antagonism of muscarinic receptors is neuroprotective in peripheral neuropathy
Nigel A. Calcutt, Darrell R. Smith, Katie Frizzi, et al.
Journal of Clinical Investigation (2017) Vol. 127, Iss. 2, pp. 608-622
Open Access | Times Cited: 81
Development of pyruvate dehydrogenase kinase inhibitors in medicinal chemistry with particular emphasis as anticancer agents
Shaolin Zhang, Xiaohui Hu, Wen Zhang, et al.
Drug Discovery Today (2015) Vol. 20, Iss. 9, pp. 1112-1119
Closed Access | Times Cited: 77
Activation of mitochondrial oxidation by PDK2 inhibition reverses cisplatin resistance in head and neck cancer
Jong‐Lyel Roh, Jin Young Park, Eun Hye Kim, et al.
Cancer Letters (2015) Vol. 371, Iss. 1, pp. 20-29
Closed Access | Times Cited: 74
Development of the First Generation of Disulfide-Based Subtype-Selective and Potent Covalent Pyruvate Dehydrogenase Kinase 1 (PDK1) Inhibitors
Yifu Liu, Zuoquan Xie, Dan Zhao, et al.
Journal of Medicinal Chemistry (2017) Vol. 60, Iss. 6, pp. 2227-2244
Closed Access | Times Cited: 70
Mitochondria-targeted betulinic and ursolic acid derivatives: synthesis and anticancer activity
Darya A. Nedopekina, Rinat R. Gubaidullin, В. Н. Одиноков, et al.
MedChemComm (2017) Vol. 8, Iss. 10, pp. 1934-1945
Open Access | Times Cited: 70
Inhibition of the pentose phosphate pathway by dichloroacetate unravels a missing link between aerobic glycolysis and cancer cell proliferation
Géraldine De Preter, Marie‐Aline Neveu, Pierre Danhier, et al.
Oncotarget (2015) Vol. 7, Iss. 3, pp. 2910-2920
Open Access | Times Cited: 67
Melatonin inhibits Warburg-dependent cancer by redirecting glucose oxidation to the mitochondria: a mechanistic hypothesis
Russel J. Reıter, Ramaswamy Sharma, Qiang Ma, et al.
Cellular and Molecular Life Sciences (2020) Vol. 77, Iss. 13, pp. 2527-2542
Open Access | Times Cited: 67
Spatial Characterization of Bioenergetics and Metabolism of Primordial to Preovulatory Follicles in Whole Ex Vivo Murine Ovary
Rachel Cinco, Michelle A. Digman, Enrico Gratton, et al.
Biology of Reproduction (2016) Vol. 95, Iss. 6, pp. 129-129
Open Access | Times Cited: 65
Obesity and Cancer Metabolism: A Perspective on Interacting Tumor–Intrinsic and Extrinsic Factors
Steven S. Doerstling, Ciara H. O’Flanagan, Stephen D. Hursting
Frontiers in Oncology (2017) Vol. 7
Open Access | Times Cited: 62
Targeting reduced mitochondrial DNA quantity as a therapeutic approach in pediatric high-grade gliomas
Han Shen, Man Yu, Maria Tsoli, et al.
Neuro-Oncology (2019) Vol. 22, Iss. 1, pp. 139-151
Open Access | Times Cited: 59
Cancer cell metabolism: Rewiring the mitochondrial hub
Gabriela Lopes Oliveira, Ana R. Coelho, Ricardo Marques, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2020) Vol. 1867, Iss. 2, pp. 166016-166016
Open Access | Times Cited: 50
Oxygen sensing, mitochondrial biology and experimental therapeutics for pulmonary hypertension and cancer
Danchen Wu, Asish Dasgupta, Austin Read, et al.
Free Radical Biology and Medicine (2021) Vol. 170, pp. 150-178
Open Access | Times Cited: 50
Restricting tumor lactic acid metabolism using dichloroacetate improves T cell functions
Hosein Rostamian, Mohammad Khakpoor-Koosheh, Leila Jafarzadeh, et al.
BMC Cancer (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 34

Scroll to top